Mounjaro is the UK brand name of the drug tirzepatide ... showing promise in clinical trials—such as an oral weight loss pill. Having alternative products available will ease strain on the ...

The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...

The guidelines are part of a national trend by municipal governments and private firms struggling to manage ballooning costs ...

GLP-1 drugs like Ozempic are injectable medications—but a strange new market has emerged selling oral “compounded” versions ...

To counter that, the government is funding a five-year trial of the weight loss drug Mounjaro, or tirzepatide, in conjunction ...

For the 12% of adults in the U.S. now taking a weight-loss medication that targets the GLP-1 and/or GIP hormones to restrict ...

Drug manufacturers are racing to develop an oral version of popular weight loss injectables like Ozempic, and early studies ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

How it works: VK2735 acts on both GLP-1 and GIP, similar to tirzepatide (the active ingredient in Mounjaro and Zepbound). It's being tested in pill form as well as a once-weekly injection.

Mounjaro, which treats type 2 diabetes ... effects and a long term commitment of lifestyle changes.” Adding: “Pills, on the other hand can be a convenient option, but may offer less dramatic ...